No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Golden Biotechnology Corporation, founded in 2002 and based in New Taipei City, Taiwan, is engaged in both pharmaceutical drug discovery and the production of health-enhancing dietary supplements. The company operates internationally, serving markets in Taiwan, the United States, Japan, China, Korea, and Singapore. Its varied product line includes several health supplements: Liverty, formulated to support liver function and help alleviate fatigue. Rasle, which serves as an adjunctive therapy for autoimmune conditions. ZSAINO, a nutritional product designed to aid recovery from illness and boost general well-being. UMOOZE, a specialized herbal blend targeting optimal health for men. Furthermore, Golden Biotechnology is developing Antroquinonol, an anticancer molecule. This compound is currently utilized in the treatment of severe conditions such as pancreatic cancer, acute myeloid leukemia, and hepatocellular carcinoma, in addition to addressing hypercholesterolemia and hyperlipidemia.
www.goldenbiotech.com/enNo one on the platform currently holds 4132.TWO.
No tracked institution reports a position in 4132.TWO as of their last filing.
No one on the platform has traded 4132.TWO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 4132.TWOGolden Biotechnology Corporation | $3.47 | +0.00% | $632M | — |
| 1796.TWOGeneFerm Biotechnology Co., Ltd. | $29.20 | +0.00% | $1.2B | — |
| 3054.TWLIWANLI Innovation Co., Ltd. | $55.60 | +1.65% | $4.5B | — |
| 4108.TWPhytoHealth Corporation | $11.30 | +0.00% | $2.2B | — |
| 4130.TWOGenovate Biotechnology Co., Ltd. | $26.70 | -0.37% | $3.1B | — |
| 4172.TWOInnoPharmax Inc. | $10.60 | -0.47% | $1.2B | — |
| 6598.TWApplied BioCode Corporation | $27.40 | +0.92% | $2.8B | — |
Source: Financial Modeling Prep · peers by sector/industry